Hiring always starts with the science. Experience, skills, and credentials are easy to measure. What actually determines success sits on the other side of that. Most hiring processes begin the same way. You look at a resume and confirm someone has done the job before. You check the boxes. [...]
If you’ve been in biotech for any length of time, you already understand one thing. Stability is never guaranteed. A company can look strong from the outside. Good funding, promising science, a pipeline that makes sense, and a hiring push that suggests momentum. Everything lines up on paper. Then [...]
If you’ve been doing this long enough, you’ve seen both sides of it. You’ve seen when everything’s growing and it almost feels like you can’t mess it up. Budgets are there, hiring’s happening, projects are getting approved. You make a few mistakes, it doesn’t really hurt you. The market [...]
Biotech companies don’t wake up one day and decide to build a messy technology environment. It happens gradually. A managed service provider gets hired to run day-to-day operations. A consultant comes in to implement a new platform. Another vendor gets brought in for security. Cloud usage expands because growth [...]
There is a hiring pattern I see in biotech that creates friction, even when the person hired is experienced and capable. On paper, the hire makes complete sense. The person has held the title before. They have worked in impressive organizations. They have led teams. They understand systems. There’s [...]
I have watched this happen to technical people more times than I can count. It usually does not announce itself. Someone who is capable and respected keeps doing what they have always done. They learn the next tool. They master the next platform. They go deeper, because going deep [...]
Over the past year, most biotech leaders I speak with have been asking variations of the same question. Not “Is the market good or bad?” but “How do we plan when things still feel uncertain?” That uncertainty hasn’t disappeared, but it has changed. Conversations are less about survival and [...]
On November 4th, I had the opportunity to speak at SIM Boston’s Life Sciences Roundtable, hosted at Dyne Therapeutics. The session focused on “The Evolving Role of the Life Sciences CIO,” and brought together about 35 to 40 biotech and pharma technology leaders, CIOs, VPs, and IT strategists, all [...]
If you're leading IT and staring down Q4 with key roles still open, let me reassure you, you’re not alone, and you’re not doomed. I’ve worked with dozens of tech leaders in the same spot: headcount’s approved, projects are lined up, but one or two critical hires are still [...]
Every fall, hiring in biotech IT ramps up, often quickly and under pressure. Companies realize they’ve got a budget to use and open roles to fill. If they don’t act soon, that money and headcount might disappear with the calendar. That’s when the panic calls start. I’ve seen it [...]
